25 XP   0   0   10

Lexicon Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Lexicon Pharmaceuticals Inc together

PenkeI guess you are interested in Lexicon Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lexicon Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Lexicon Pharmaceuticals Inc

I send you an email if I find something interesting about Lexicon Pharmaceuticals Inc.

Quick analysis of Lexicon Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Lexicon Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$0.48
Expected worth in 1 year
$0.48
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
$2.19
Expected price per share
$1.67 - $3.73
How sure are you?
50%

1. Valuation of Lexicon Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$2.19

Intrinsic Value Per Share

$-3.75 - $-1.86

Total Value Per Share

$-3.27 - $-1.38

2. Growth of Lexicon Pharmaceuticals Inc (5 min.)




Is Lexicon Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$117.1m$117.1m0.000.0%

How much money is Lexicon Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$175.6m-$103.1m-$72.4m-41.3%
Net Profit Margin-14,585.3%-74,192.8%--

How much money comes from the company's main activities?

3. Financial Health of Lexicon Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#360 / 1031

Most Revenue
#480 / 1031

Most Profit
#1020 / 1031

Most Efficient
#972 / 1031

What can you expect buying and holding a share of Lexicon Pharmaceuticals Inc? (5 min.)

Welcome investor! Lexicon Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Lexicon Pharmaceuticals Inc.

What can you expect buying and holding a share of Lexicon Pharmaceuticals Inc?

First you should know what it really means to hold a share of Lexicon Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Lexicon Pharmaceuticals Inc is $2.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lexicon Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lexicon Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.48. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lexicon Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.71-32.6%-0.71-32.6%-0.41-18.9%-0.24-10.9%-0.32-14.6%
Usd Book Value Change Per Share0.000.0%0.000.0%0.010.7%0.125.3%-0.02-1.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.198.5%0.094.3%
Usd Total Gains Per Share0.000.0%0.000.0%0.010.7%0.3013.8%0.073.3%
Usd Price Per Share1.53-1.53-1.91-2.99-5.95-
Price to Earnings Ratio-2.15--2.15--4.61--4.87--78.31-
Price-to-Total Gains Ratio133.27-28.12-203.62-
Price to Book Ratio3.22-3.22-4.02-5.98-4.85-
Price-to-Total Gains Ratio133.27-28.12-203.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.19
Number of shares456
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.19
Usd Book Value Change Per Share0.000.12
Usd Total Gains Per Share0.000.30
Gains per Quarter (456 shares)0.00137.71
Gains per Year (456 shares)0.00550.83
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-10338213541
200-106764251092
300-1010156381643
400-1013538512194
500-10169110632745
600-10202912763296
700-10236714883847
800-10270617014398
900-10304419144949
1000-10338221265500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%1.024.00.04.0%
Book Value Change Per Share0.00.01.00.0%1.01.01.033.3%3.01.01.060.0%5.04.01.050.0%11.013.01.044.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%2.00.03.040.0%3.00.07.030.0%5.00.020.020.0%
Total Gains per Share0.00.01.00.0%1.01.01.033.3%3.01.01.060.0%5.04.01.050.0%11.013.01.044.0%

Fundamentals of Lexicon Pharmaceuticals Inc

About Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Fundamental data was last updated by Penke on 2024-03-20 23:13:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Lexicon Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lexicon Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -14,585.3% means that $-145.85 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is -14,585.3%. The company is making a huge loss. -2
  • The TTM is -14,585.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14,585.3%TTM-14,585.3%0.0%
TTM-14,585.3%YOY-74,192.8%+59,607.5%
TTM-14,585.3%5Y-23,730.1%+9,144.8%
5Y-23,730.1%10Y-11,959.6%-11,770.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14,585.3%-171.8%-14,413.5%
TTM-14,585.3%-205.8%-14,379.5%
YOY-74,192.8%-262.1%-73,930.7%
5Y-23,730.1%-455.6%-23,274.5%
10Y-11,959.6%-589.0%-11,370.6%
1.1.2. Return on Assets

Shows how efficient Lexicon Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • -90.4% Return on Assets means that Lexicon Pharmaceuticals Inc generated $-0.90 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is -90.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -90.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-90.4%TTM-90.4%0.0%
TTM-90.4%YOY-53.1%-37.3%
TTM-90.4%5Y-42.2%-48.1%
5Y-42.2%10Y-33.5%-8.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-90.4%-12.5%-77.9%
TTM-90.4%-12.2%-78.2%
YOY-53.1%-11.2%-41.9%
5Y-42.2%-13.4%-28.8%
10Y-33.5%-14.7%-18.8%
1.1.3. Return on Equity

Shows how efficient Lexicon Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • -112.3% Return on Equity means Lexicon Pharmaceuticals Inc generated $-1.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is -112.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -112.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-112.3%TTM-112.3%0.0%
TTM-112.3%YOY--112.3%
TTM-112.3%5Y-31.4%-80.9%
5Y-31.4%10Y-53.2%+21.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-112.3%-15.8%-96.5%
TTM-112.3%-15.7%-96.6%
YOY--13.9%+13.9%
5Y-31.4%-18.3%-13.1%
10Y-53.2%-19.2%-34.0%

1.2. Operating Efficiency of Lexicon Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lexicon Pharmaceuticals Inc is operating .

  • Measures how much profit Lexicon Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-72,489.2%+72,489.2%
TTM-5Y-20,483.0%+20,483.0%
5Y-20,483.0%10Y-10,326.0%-10,157.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM--210.1%+210.1%
YOY-72,489.2%-279.7%-72,209.5%
5Y-20,483.0%-459.9%-20,023.1%
10Y-10,326.0%-596.9%-9,729.1%
1.2.2. Operating Ratio

Measures how efficient Lexicon Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 143.65 means that the operating costs are $143.65 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 143.650. The company is inefficient in keeping operating costs low. -1
  • The TTM is 143.650. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ143.650TTM143.6500.000
TTM143.650YOY728.964-585.315
TTM143.6505Y271.901-128.251
5Y271.90110Y138.008+133.893
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ143.6502.861+140.789
TTM143.6503.193+140.457
YOY728.9643.615+725.349
5Y271.9015.560+266.341
10Y138.0087.396+130.612

1.3. Liquidity of Lexicon Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lexicon Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY6.079-6.079
TTM-5Y3.727-3.727
5Y3.72710Y4.065-0.338
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.986-3.986
TTM-4.440-4.440
YOY6.0795.552+0.527
5Y3.7276.158-2.431
10Y4.0656.492-2.427
1.3.2. Quick Ratio

Measures if Lexicon Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY9.943-9.943
TTM-5Y5.467-5.467
5Y5.46710Y6.144-0.677
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.638-3.638
TTM-4.168-4.168
YOY9.9435.515+4.428
5Y5.4676.012-0.545
10Y6.1446.209-0.065

1.4. Solvency of Lexicon Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lexicon Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lexicon Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.40 means that Lexicon Pharmaceuticals Inc assets are financed with 39.7% credit (debt) and the remaining percentage (100% - 39.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 0.397. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.397. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.397TTM0.3970.000
TTM0.397YOY0.3970.000
TTM0.3975Y0.383+0.014
5Y0.38310Y0.552-0.169
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3970.335+0.062
TTM0.3970.330+0.067
YOY0.3970.267+0.130
5Y0.3830.367+0.016
10Y0.5520.378+0.174
1.4.2. Debt to Equity Ratio

Measures if Lexicon Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 49.4% means that company has $0.49 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 0.494. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.494. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.494TTM0.4940.000
TTM0.494YOY-+0.494
TTM0.4945Y0.159+0.334
5Y0.15910Y1.215-1.055
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4940.376+0.118
TTM0.4940.398+0.096
YOY-0.334-0.334
5Y0.1590.429-0.270
10Y1.2150.476+0.739

2. Market Valuation of Lexicon Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lexicon Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -2.15 means the investor is paying $-2.15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lexicon Pharmaceuticals Inc:

  • The EOD is -3.071. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.145. Based on the earnings, the company is expensive. -2
  • The TTM is -2.145. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.071MRQ-2.145-0.925
MRQ-2.145TTM-2.1450.000
TTM-2.145YOY-4.613+2.468
TTM-2.1455Y-4.868+2.722
5Y-4.86810Y-78.307+73.439
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.071-2.643-0.428
MRQ-2.145-2.418+0.273
TTM-2.145-2.742+0.597
YOY-4.613-4.123-0.490
5Y-4.868-6.257+1.389
10Y-78.307-6.478-71.829
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lexicon Pharmaceuticals Inc:

  • The EOD is -4.005. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.798. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.798. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.005MRQ-2.798-1.207
MRQ-2.798TTM-2.7980.000
TTM-2.798YOY-5.215+2.417
TTM-2.7985Y-3.182+0.384
5Y-3.18210Y-4.451+1.269
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.005-3.244-0.761
MRQ-2.798-2.939+0.141
TTM-2.798-3.478+0.680
YOY-5.215-5.592+0.377
5Y-3.182-8.473+5.291
10Y-4.451-8.881+4.430
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lexicon Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.22 means the investor is paying $3.22 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Lexicon Pharmaceuticals Inc:

  • The EOD is 4.604. Based on the equity, the company is fair priced.
  • The MRQ is 3.217. Based on the equity, the company is fair priced.
  • The TTM is 3.217. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.604MRQ3.217+1.388
MRQ3.217TTM3.2170.000
TTM3.217YOY4.016-0.799
TTM3.2175Y5.977-2.760
5Y5.97710Y4.855+1.122
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.6042.124+2.480
MRQ3.2172.041+1.176
TTM3.2172.118+1.099
YOY4.0162.915+1.101
5Y5.9773.682+2.295
10Y4.8554.114+0.741
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Lexicon Pharmaceuticals Inc.

3.1. Institutions holding Lexicon Pharmaceuticals Inc

Institutions are holding 77.58% of the shares of Lexicon Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Artal Group S A48.17275.979111755328400
2023-09-30Bvf Inc8.1940.58771999533200
2023-12-31BlackRock Inc2.87070.000370051533501875.262
2023-12-31Vanguard Group Inc2.45070.00025980371-419840-6.5598
2023-12-31JPMorgan Chase & Co1.24710.000530432912282578.1085
2023-12-31NEA Management Company, LLC0.97620.2429238228600
2023-12-31Geode Capital Management, LLC0.96260.0004234891622277910.4781
2023-12-31FMR Inc0.93290.00032276468-5286608-69.9002
2023-09-30Octagon Capital Advisors LP0.78810.322192307600
2023-12-31State Street Corporation0.77550.00011892319161800.8624
2023-12-31Ameriprise Financial Inc0.77460.0009189020067552255.6133
2023-12-31Pinnacle Associates Inc0.70930.04461730821-182048-9.517
2023-12-31Millennium Management LLC0.66930.00111633176-2252577-57.9702
2023-12-31Morgan Stanley - Brokerage Accounts0.37610.0001917688678068282.9764
2023-12-31Charles Schwab Investment Management Inc0.35410.0003864175122541.4384
2023-12-31Northern Trust Corp0.35230.0002859588-291229-25.3063
2023-09-30D. E. Shaw & Co LP0.32130.0009784122-429604-35.3955
2023-12-31GSA Capital Partners LLP0.31970.10047800777800770
2023-09-30Alyeska Investment Group, L.P.0.20880.0038509484-1232868-70.7588
2023-12-31Goldman Sachs Group Inc0.19290.000147067811096730.8489
Total 71.64897.2859174840505-7020483-4.0%

3.2. Funds holding Lexicon Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.51740.0006370277400
2024-02-29iShares Russell 2000 ETF0.93280.00912276254-372-0.0163
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.73080.0044178342018031611.2479
2024-01-31JPMorgan Small Cap Value I0.60050.1934146528400
2023-12-31Columbia Small Cap Value I0.50360.1377122894544027555.825
2024-02-29Columbia Small Cap Value I A0.50310.22971227645-9600-0.7759
2024-01-31CREF Stock R10.44270.00171080195885415454.5718
2023-12-31Fidelity Small Cap Index0.37370.005591183586810.9612
2024-01-31Fidelity Growth Compy Commingled Pl O0.35510.0023866617-1405000-61.8502
2024-01-31Fidelity Extended Market Index0.27810.003567855000
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.24080.003558768200
2024-02-29Schwab US Small-Cap ETF™0.2330.00956847400
2024-02-01iShares Russell 2000 Value ETF0.21130.00865157076520.1266
2024-01-31VALIC Company I Small Cap Value0.20670.1901504423-13173-2.545
2024-02-29Columbia VP Small Cap Value 10.19940.228548660800
2024-02-29iShares Russell 2000 Growth ETF0.16150.0086394087-458-0.1161
2023-12-31BrighthouseI JPMorgan Small Cap Value A0.16050.151939161055401.435
2024-02-29State St Russell Sm Cap® Indx SL Cl I0.1430.009234892200
2024-02-29iShares Core S&P Total US Stock Mkt ETF0.14180.001634596200
2024-02-29Vanguard Russell 2000 ETF0.13630.0087332641263448.6008
Total 8.07211.207619697635+118620+0.6%

3.3. Insider Transactions

Insiders are holding 1.646% of the shares of Lexicon Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-16Lonnel CoatsBUY900001.05
2023-11-10Lonnel CoatsBUY100001.01
2023-10-12Raymond DebbaneBUY1488201.03
2023-10-10Raymond DebbaneBUY5083061.14
2023-09-14Jeffrey L WadeBUY100001.38
2023-08-04Wendy McdermottBUY60001.84
2023-06-29Lonnel CoatsBUY100002.16
2023-06-26Lonnel CoatsBUY100002.18
2023-06-23Wendy McdermottBUY100002.43
2023-06-22Lonnel CoatsBUY400002.31
2023-06-20Jeffrey L WadeBUY120002.33
2023-06-05International S.c.a. ArtalBUY277750502.6

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Lexicon Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%0.014-100%0.117-100%-0.0220%
Book Value Per Share--0.4760.4760%0.4760%0.505-6%0.558-15%
Current Ratio----0%6.079-100%3.727-100%4.065-100%
Debt To Asset Ratio--0.3970.3970%0.3970%0.383+4%0.552-28%
Debt To Equity Ratio--0.4940.4940%-+100%0.159+210%1.215-59%
Dividend Per Share----0%-0%0.185-100%0.094-100%
Eps---0.713-0.7130%-0.414-42%-0.239-67%-0.321-55%
Free Cash Flow Per Share---0.547-0.5470%-0.366-33%-0.278-49%-0.302-45%
Free Cash Flow To Equity Per Share--0.3180.3180%0.211+50%-0.093+129%-0.035+111%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.860--------
Intrinsic Value_10Y_min---3.747--------
Intrinsic Value_1Y_max---0.259--------
Intrinsic Value_1Y_min---0.416--------
Intrinsic Value_3Y_max---0.723--------
Intrinsic Value_3Y_min---1.222--------
Intrinsic Value_5Y_max---1.120--------
Intrinsic Value_5Y_min---1.991--------
Market Cap539259012.480+30%376742597.760376742597.7600%470312654.720-20%736248606.080-49%1465600114.014-74%
Net Profit Margin---145.853-145.8530%-741.928+409%-237.301+63%-119.596-18%
Operating Margin----0%-724.8920%-204.8300%-103.2600%
Operating Ratio--143.650143.6500%728.964-80%271.901-47%138.008+4%
Pb Ratio4.604+30%3.2173.2170%4.016-20%5.977-46%4.855-34%
Pe Ratio-3.071-43%-2.145-2.1450%-4.613+115%-4.868+127%-78.307+3550%
Price Per Share2.190+30%1.5301.5300%1.910-20%2.990-49%5.952-74%
Price To Free Cash Flow Ratio-4.005-43%-2.798-2.7980%-5.215+86%-3.182+14%-4.451+59%
Quick Ratio----0%9.943-100%5.467-100%6.144-100%
Return On Assets---0.904-0.9040%-0.531-41%-0.422-53%-0.335-63%
Return On Equity---1.123-1.1230%--100%-0.314-72%-0.532-53%
Total Gains Per Share----0%0.014-100%0.302-100%0.072-100%
Usd Book Value--117124000.000117124000.0000%117124000.0000%124263000.000-6%137428100.000-15%
Usd Book Value Change Per Share----0%0.014-100%0.117-100%-0.0220%
Usd Book Value Per Share--0.4760.4760%0.4760%0.505-6%0.558-15%
Usd Dividend Per Share----0%-0%0.185-100%0.094-100%
Usd Eps---0.713-0.7130%-0.414-42%-0.239-67%-0.321-55%
Usd Free Cash Flow---134634000.000-134634000.0000%-90177000.000-33%-68473600.000-49%-74438700.000-45%
Usd Free Cash Flow Per Share---0.547-0.5470%-0.366-33%-0.278-49%-0.302-45%
Usd Free Cash Flow To Equity Per Share--0.3180.3180%0.211+50%-0.093+129%-0.035+111%
Usd Market Cap539259012.480+30%376742597.760376742597.7600%470312654.720-20%736248606.080-49%1465600114.014-74%
Usd Price Per Share2.190+30%1.5301.5300%1.910-20%2.990-49%5.952-74%
Usd Profit---175607000.000-175607000.0000%-103128000.000-41%-61410800.000-65%-80305700.000-54%
Usd Revenue--1204000.0001204000.0000%139000.000+766%69541800.000-98%73745800.000-98%
Usd Total Gains Per Share----0%0.014-100%0.302-100%0.072-100%
 EOD+5 -2MRQTTM+0 -0YOY+7 -205Y+6 -2710Y+6 -25

4.2. Fundamental Score

Let's check the fundamental score of Lexicon Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.071
Price to Book Ratio (EOD)Between0-14.604
Net Profit Margin (MRQ)Greater than0-145.853
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than10.397
Debt to Equity Ratio (MRQ)Less than10.494
Return on Equity (MRQ)Greater than0.15-1.123
Return on Assets (MRQ)Greater than0.05-0.904
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Lexicon Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.930
Ma 20Greater thanMa 502.360
Ma 50Greater thanMa 1002.278
Ma 100Greater thanMa 2001.773
OpenGreater thanClose2.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
 As reported
Total Liabilities 0
Total Stockholder Equity+ 0
Total Assets = 0

Assets

Total Current Assets
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Common Stock Shares Outstanding 221,130



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
> Total Assets 
22,300
220,693
239,990
201,772
284,199
211,980
218,714
190,266
369,296
261,508
257,761
366,884
430,512
371,778
274,160
471,376
654,832
475,625
436,539
284,136
417,715
203,788
136,909
194,299
0
0194,299136,909203,788417,715284,136436,539475,625654,832471,376274,160371,778430,512366,884257,761261,508369,296190,266218,714211,980284,199201,772239,990220,69322,300
   > Total Current Assets 
12,600
206,032
166,442
133,132
171,505
98,748
106,047
85,552
264,650
109,167
169,684
214,738
281,692
230,935
134,554
368,987
532,400
357,874
321,995
173,324
337,754
157,719
88,921
140,866
0
0140,86688,921157,719337,754173,324321,995357,874532,400368,987134,554230,935281,692214,738169,684109,167264,65085,552106,04798,748171,505133,132166,442206,03212,600
       Cash And Cash Equivalents 
2,000
37,811
23,048
39,362
81,915
14,612
21,970
30,226
22,938
85,873
100,554
47,208
281,692
223,208
129,128
339,339
521,352
346,504
310,788
160,052
36,112
126,263
64,065
46,345
0
046,34564,065126,26336,112160,052310,788346,504521,352339,339129,128223,208281,69247,208100,55485,87322,93830,22621,97014,61281,91539,36223,04837,8112,000
       Short-term Investments 
7,100
164,869
133,394
54,247
22,123
72,946
77,725
49,773
235,837
17,239
61,959
163,903
95,383
192,785
91,629
202,073
318,363
299,904
249,127
79,666
235,547
26,012
22,678
92,012
0
092,01222,67826,012235,54779,666249,127299,904318,363202,07391,629192,78595,383163,90361,95917,239235,83749,77377,72572,94622,12354,247133,394164,8697,100
       Net Receivables 
3,400
2,815
4,544
5,143
6,571
6,397
2,608
1,186
1,763
568
815
744
350
1,378
790
1,035
911
7,492
4,825
5,924
56,532
395
14
28
0
0281439556,5325,9244,8257,4929111,0357901,3783507448155681,7631,1862,6086,3976,5715,1434,5442,8153,400
       Other Current Assets 
100
536
5,456
34,380
60,896
4,793
3,744
4,367
4,112
5,487
6,356
2,883
3,748
6,349
4,636
23,849
10,137
3,878
4,434
2,668
5,320
5,049
2,164
2,481
0
02,4812,1645,0495,3202,6684,4343,87810,13723,8494,6366,3493,7482,8836,3565,4874,1124,3673,7444,79360,89634,3805,456536100
   > Long-term Assets 
9,700
14,661
73,548
68,640
112,694
113,232
112,667
104,714
104,646
152,341
88,077
152,146
148,820
140,843
139,606
102,389
122,432
117,751
114,544
110,812
79,961
46,069
47,988
53,433
0
053,43347,98846,06979,961110,812114,544117,751122,432102,389139,606140,843148,820152,14688,077152,341104,646104,714112,667113,232112,69468,64073,54814,6619,700
       Property Plant Equipment 
9,400
14,477
26,707
37,362
83,676
84,573
85,265
78,192
70,829
65,087
58,754
53,427
46,417
42,634
41,362
1,080
21,227
19,390
17,687
15,865
14,047
295
1,176
2,071
0
02,0711,17629514,04715,86517,68719,39021,2271,08041,36242,63446,41753,42758,75465,08770,82978,19285,26584,57383,67637,36226,70714,4779,400
       Goodwill 
0
0
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
0
044,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54325,79825,79825,79825,79825,79825,79825,79825,79825,79800
       Intangible Assets 
0
0
5,440
30,038
28,838
27,638
26,438
25,798
25,798
25,798
25,798
53,557
53,557
53,557
53,557
53,357
53,357
53,357
51,885
50,119
19,716
0
0
0
0
000019,71650,11951,88553,35753,35753,35753,55753,55753,55753,55725,79825,79825,79825,79826,43827,63828,83830,0385,44000
       Long-term Assets Other 
300
184
15,603
1,240
180
1,021
964
724
8,019
61,456
3,525
619
4,303
109
144
3,409
3,305
461
429
285
1,655
1,231
2,269
6,819
0
06,8192,2691,2311,6552854294613,3053,4091441094,3036193,52561,4568,0197249641,0211801,24015,603184300
> Total Liabilities 
14,100
13,064
21,618
31,870
117,983
90,386
132,912
104,765
82,725
65,681
94,264
119,860
132,944
105,100
103,997
187,358
368,982
318,224
384,437
310,541
300,614
47,417
23,314
77,175
0
077,17523,31447,417300,614310,541384,437318,224368,982187,358103,997105,100132,944119,86094,26465,68182,725104,765132,91290,386117,98331,87021,61813,06414,100
   > Total Current Liabilities 
10,600
11,231
18,779
21,299
31,766
38,710
57,463
45,966
35,347
21,176
50,954
10,775
24,894
18,285
19,294
44,969
122,996
164,643
124,127
36,751
65,341
46,806
22,124
23,172
0
023,17222,12446,80665,34136,751124,127164,643122,99644,96919,29418,28524,89410,77550,95421,17635,34745,96657,46338,71031,76621,29918,77911,23110,600
       Short-term Debt 
9,400
1,012
0
0
0
4,691
4,751
816
880
963
38,482
1,138
24,894
1,574
1,710
20,167
2,015
16,280
14,094
1,115
11,012
12,199
1,089
1,291
0
01,2911,08912,19911,0121,11514,09416,2802,01520,1671,7101,57424,8941,13838,4829638808164,7514,6910001,0129,400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,167
1,976
16,280
14,094
1,115
11,012
11,646
0
0
0
00011,64611,0121,11514,09416,2801,97620,167000000000000000
       Accounts payable 
1,200
5,546
3,168
4,378
5,884
7,574
6,883
6,513
7,344
7,926
5,919
3,159
6,042
7,661
9,715
13,064
19,725
52,877
57,652
17,759
12,178
5,469
9,152
10,395
0
010,3959,1525,46912,17817,75957,65252,87719,72513,0649,7157,6616,0423,1595,9197,9267,3446,5136,8837,5745,8844,3783,1685,5461,200
       Other Current Liabilities 
9,400
4,672
5,016
4,161
4,757
6,945
6,787
7,325
9,093
6,615
5,611
6,264
-6,161
8,922
7,674
10,120
24,757
32,114
12,282
14,482
42,151
976
11,883
11,486
0
011,48611,88397642,15114,48212,28232,11424,75710,1207,6748,922-6,1616,2645,6116,6159,0937,3256,7876,9454,7574,1615,0164,6729,400
   > Long-term Liabilities 
3,500
1,834
2,839
10,571
86,217
51,676
75,449
58,799
47,378
44,505
43,310
109,085
108,050
86,815
84,703
142,389
245,986
153,581
260,310
273,790
235,273
611
1,190
54,003
0
054,0031,190611235,273273,790260,310153,581245,986142,38984,70386,815108,050109,08543,31044,50547,37858,79975,44951,67686,21710,5712,8391,8343,500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
23,451
21,877
20,167
87,500
103,793
85,167
231,576
243,887
234,171
0
0
0
0
0000234,171243,887231,57685,167103,79387,50020,16721,87723,451000000000000
       Other Liabilities 
0
0
2,839
6,571
29,873
18,736
43,260
27,427
16,885
14,976
14,828
62,995
69,358
46,193
45,791
36,214
142,193
68,414
31,209
29,903
55,431
35,771
23,314
0
0
0023,31435,77155,43129,90331,20968,414142,19336,21445,79146,19369,35862,99514,82814,97616,88527,42743,26018,73629,8736,5712,83900
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
32,957
32,655
32,150
31,354
127,826
67,609
28,442
29,665
0
0
0
0
0
0000029,66528,44267,609127,82631,35432,15032,65532,957000000000000
> Total Stockholder Equity
8,200
207,628
218,372
169,902
166,216
121,594
85,802
85,501
256,300
185,580
163,787
247,024
297,568
266,678
-1,003,959
284,018
285,850
157,401
52,102
-1,471,577
-1,341,444
156,371
-1,487,776
-1,589,720
0
0-1,589,720-1,487,776156,371-1,341,444-1,471,57752,102157,401285,850284,018-1,003,959266,678297,568247,024163,787185,580256,30085,50185,802121,594166,216169,902218,372207,6288,200
   Common Stock
-32,300
48
52
52
63
63
64
78
137
137
176
338
480
512
514
726
104
105
106
106
106
142
150
189
0
018915014210610610610510472651451248033817613713778646363525248-32,300
   Retained Earnings Total Equity0-1,589,720-1,487,776-1,400,018-1,341,444-1,471,577-1,381,404-1,250,363-1,108,934-1,104,252-1,003,958-899,832-789,621000000000000
   Accumulated Other Comprehensive Income 
-900
-33,637
-22,697
-11,106
-899
-20
-54
-16
-4
-71,102
-75,795
5
21
23
2
-63
-219
-195
-222
-12
84
-6
-10
-428
0
0-428-10-684-12-222-195-219-63223215-75,795-71,102-4-16-54-20-899-11,106-22,697-33,637-900
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
1,087,033
1,166,605
1,175,108
1,389,997
1,397,646
1,411,222
1,435,526
1,447,954
1,462,172
1,561,096
1,608,749
1,709,144
0
01,709,1441,608,7491,561,0961,462,1721,447,9541,435,5261,411,2221,397,6461,389,9971,175,1081,166,6051,087,033000000000000
   Treasury Stock0-2,061-7,518-4,843-3,817-2,876-1,904-3,368-2,747-2,390-1,503-630-345-237-880000000000
   Other Stockholders Equity 
40,200
268,191
319,142
330,701
380,995
382,666
383,222
437,180
666,702
672,838
809,581
920,087
1,086,688
1,165,975
1,173,605
1,387,607
1,394,899
1,407,854
1,433,622
-94
-190
1,556,253
-140
239
0
0239-1401,556,253-190-941,433,6221,407,8541,394,8991,387,6071,173,6051,165,9751,086,688920,087809,581672,838666,702437,180383,222382,666380,995330,701319,142268,19140,200



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,204
Cost of Revenue-85
Gross Profit1,1191,119
 
Operating Income (+$)
Gross Profit1,119
Operating Expense-172,869
Operating Income-171,750-171,750
 
Operating Expense (+$)
Research Development58,887
Selling General Administrative97,704
Selling And Marketing Expenses0
Operating Expense172,869156,591
 
Net Interest Income (+$)
Interest Income6,217
Interest Expense-11,589
Other Finance Cost-2,806
Net Interest Income-2,566
 
Pretax Income (+$)
Operating Income-171,750
Net Interest Income-2,566
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-175,607-167,893
EBIT - interestExpense = -11,589
-175,607
-164,018
Interest Expense11,589
Earnings Before Interest and Taxes (EBIT)0-164,018
Earnings Before Interest and Taxes (EBITDA)-171,750
 
After tax Income (+$)
Income Before Tax-175,607
Tax Provision-0
Net Income From Continuing Ops-157,857-175,607
Net Income-175,607
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses172,954
Total Other Income/Expenses Net-3,8572,566
 

Technical Analysis of Lexicon Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lexicon Pharmaceuticals Inc. The general trend of Lexicon Pharmaceuticals Inc is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lexicon Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lexicon Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.09 < 2.8291 < 3.73.

The bearish price targets are: 1.93 > 1.67 > 1.67.

Tweet this
Lexicon Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lexicon Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lexicon Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lexicon Pharmaceuticals Inc. The current macd is -0.04127927.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lexicon Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lexicon Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lexicon Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Lexicon Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartLexicon Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lexicon Pharmaceuticals Inc. The current adx is 23.20.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Lexicon Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Lexicon Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lexicon Pharmaceuticals Inc. The current sar is 2.73993048.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Lexicon Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lexicon Pharmaceuticals Inc. The current rsi is 45.93. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Lexicon Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartLexicon Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lexicon Pharmaceuticals Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lexicon Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Lexicon Pharmaceuticals Inc Daily Stochastic Oscillator ChartLexicon Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lexicon Pharmaceuticals Inc. The current cci is -92.5572075.

Lexicon Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartLexicon Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lexicon Pharmaceuticals Inc. The current cmo is -12.93093764.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lexicon Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartLexicon Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lexicon Pharmaceuticals Inc. The current willr is -73.53584168.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Lexicon Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Lexicon Pharmaceuticals Inc Daily Williams %R ChartLexicon Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lexicon Pharmaceuticals Inc. The current atr is 0.24210177.

Lexicon Pharmaceuticals Inc Daily Average True Range (ATR) ChartLexicon Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lexicon Pharmaceuticals Inc. The current obv is 53,055,942.

Lexicon Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartLexicon Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lexicon Pharmaceuticals Inc. The current mfi is 57.39.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Lexicon Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartLexicon Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lexicon Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Lexicon Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lexicon Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.930
Ma 20Greater thanMa 502.360
Ma 50Greater thanMa 1002.278
Ma 100Greater thanMa 2001.773
OpenGreater thanClose2.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lexicon Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Lexicon Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lexicon Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lexicon Pharmaceuticals Inc

I send you an email if I find something interesting about Lexicon Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Lexicon Pharmaceuticals Inc.

Receive notifications about Lexicon Pharmaceuticals Inc in your mailbox!